Navidea Biopharmaceuticals Inc (NYSE American:NAVB)

0.291
Delayed Data
As of Apr 20
 -0.0085 / -2.84%
Today’s Change
0.29
Today|||52-Week Range
0.68
-18.83%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-35.7M-27.6M-14.3M74.9M
 
 
 
 
 
Depreciation500.2K571.4K501.4K254.6K
 
 
 
 
 
Total Other Cash Flow7.7M9.1M4.3M9.1M
 
 
 
 
 
Funds From Operations-27.6M-17.9M-9.5M84.3M
 
 
 
 
 
Funds From/For Other Operating Expenses1.6M1.2M-13.1M25.2M
 
 
 
 
 
Net Cash Flow - Operating Activities-29.1M-19.1M3.6M59.1M
 
 
 
 
 
 
InvestingIncrease In Investments-333.3K0.00-110.0K-2.2M
 
 
 
 
Decrease In Investments0.000.0027.6K400.0K
 
 
 
Capital Expenditures-1.1M-39.0K-1.8K-33.7K
 
 
 
 
 
Fixed Asset Disposal--38.3K45.0K0.00
 
 
 
Net Cash Flow Investing-1.5M-27.8K-39.2K-1.8M
 
 
 
 
 
 
FinancingShort Term Borrowings------0.00--
Long Term Borrowings28.2M50.6M-3.9M-1.3M
 
 
 
 
 
Long Term Debt Reduction-25.0M-30.3M-233.6K-59.8M
 
 
 
 
 
Net Proceeds Stock Sale88.0K553.4K13.6K72.4K
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.00--0.00--
Cash Dividends Paid - Total0.000.00--0.00--
Other Sources - Financing----0.000.00--
Other Uses - Financing130.5K23.9K0.000.00
 
 
 
Net Cash Flow - Financing3.2M20.8M-4.1M-61.0M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash-27.5M1.7M-625.7K-3.7M